Our Recommendations
- Module: Disorders due to substance abuse mhGAP (2019)
- Групповая интерперсональная терапия (ипт) при депрессии (2018)
- Guía de intervención mhGAP para los trastornos mentales, neurológicos y por consumo de sustancias en el nivel de atención de salud no especializada Versión 2.0 (2017)
- mhGAP Intervention Guide Mental Health Gap Action Programme Version 2.0 for mental, neurological and substance use disorders in non-specialized health settings (2016)
- MhGAP Child and adolescent mental and behavioural disorders, slides. (2010)
New Publications
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP) (2023)
- mhGAP Humanitarian Intervention Guide (mhGAP-HIG) training of health-care providers. Training manual (2022)
- Implementing the mental health Gap Action Programme intervention guide (2021)
Filter
105
Featured
Recommendations
30
New Publications
6
Language
Document type
No document type
69
Training Material
14
Manuals
12
Guidelines
4
Fact sheets
3
Resource Platforms
2
Studies & Reports
1
Countries / Regions
Ukraine
3
Syria
3
Russia
3
Nepal
2
Global
2
Western and Central Europe
2
Eastern Europe
2
South Sudan
2
Kenya
1
Middle East and North Africa
1
Authors & Publishers
Publication Years
Category
Neurology & Psychology
9
Training Manuals
3
Guidelines
2
Mental Health
2
Humanitarian Aid
1
Mobile Training Tools & Apps
1
Toolboxes
Training Supporting Material mhGAP
64
mhGAP Guides
30
Modules
11
What can you expect?
As a future facilitator your role will be to learn about the structure of mhGAP-IG, how to teach the materials and utilize opportunities to prastice facilitation and supervision skills.
As a supervisor your role will be to serve as a point of reference for non-specialized heal...
This module should always be used together with the
mhGAP Intervention Guide for Mental, Neurological
and Substance Use Disorders in Non-specialized Health
Settings (WHO, 2010), which outlines relevant general
principles of care and management of a range of other
mental, neurological and substa...
Q 1: Are antidepressants (Tricyclic Antidepressants (TCA) and Selective Serotonin Reuptake Inhibitors (SSRI)) better (more
effective than/as safe as) than treatment as usual (placebo) in adults with depressive episode/disorder?
Q 3: Is brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with depressive episode/disorder?
Q 4: Is behavioural activation better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?brief, structured psychological treatment in non-specialist health care settings better (more effective than/as safe as) than treatment as usual in people with de...
Second-generation antipsychotic medications for psychotic disorders (including schizophrenia)
recommended
Q14. SCOPING QUESTION: In adults with psychotic disorders (including schizophrenia), what is the comparative effectiveness and safety of second-generation antipsychotic medications?
Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?
Learning objectives
• Promote respect and dignity for people with self-harm/suicide.
• Know the common presentations of self-harm/suicide.
• Know the principles of assessment of self-harm/suicide.
• Know the management principles of self-harm/suicide.
• Perform an assessment for self-...
Q6: Is advice on physical activity better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder with inactive lifestyles
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Q3: Can febrile seizures (simple or complex) be managed at first or second level care by non-specialist health care providers in low and middle income country settings? What is the role of diagnostic tests in the management of febrile seizures by non-specialists in low and middle income settings? Fo...
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
Q4: Can convulsive epilepsy be diagnosed at first level care by a non-specialist health care provider in low and middle income country settings?
Q10: In individuals with psychotic disorders (including schizophrenia) and bipolar disorders are psychoeducation, family interventions and cognitive-behavioural therapy feasible and effective?
